Yesterday I anticipated that, in the interests of narrative over information, some writers would probably try to turn the Melky Cabrera and Bartolo Colon PED suspensions into some larger story about Bay Area drug corruption with callbacks to the days of BALCO, Canseco and Bonds.
And I was not disappointed. John Shea:
The steroid cloud that once hovered over Jose Canseco, Mark McGwire and Jason Giambi and Co. in Oakland, and Barry Bonds and his BALCO brethren in San Francisco, is back by the bay.
First we had the steroid-enhanced A’s of the late ’80s and early ’90s, led by Jose Canseco and Mark McGwire. Then came the BALCO scandal, with Barry Bonds and several lesser Giants as the central figures. The 2007 Mitchell Report implicated players associated with both Bay Area teams, and recent years have brought more drug-related suspensions, most recently the bombshells that sidelined Cabrera and Colon in the middle of highly influential seasons.
It keeps happening, and most specifically, it keeps happening in the Bay Area, home of two baseball teams and a seemingly endless amount of PED use … The Bay Area is the Hometown of Steroids …
Of course, it starts with the whole sordid history of BALCO (the Bay Area Laboratory Co-Operative) and Barry Bonds and the early steroid adventures of Jose Canseco and Mark McGwire. The Mitchell Report was littered with the names of Bay Area players; now, years later, the Bay Area is home to three players testing positive for PED use.
I don’t begrudge a writer using a framing device. But this particular framing device — BALCO, Bonds, Canseco, etc. — is highly misleading. It creates the impression that the problem is bigger than it truly is and implies connections where there are none.
The subject of PEDs in sports is rife with overheated and misleading rhetoric. What it lacks is actual factual reporting and constructive commentary and ideas. This kind of thing isn’t helping.
Former Tigers infielder Casey McGehee has reportedly signed a one-year deal with the Yomiuri Giants of Nippon Professional Baseball, according to FOX Sports’ Ken Rosenthal.
It’s the fourth move the corner infielder has made in the last two seasons after seeing short-term stints with the Marlins, Giants and Tigers. He signed a minor league deal with the Tigers prior to the 2016 season, providing the club with some infield depth behind 24-year-old Nick Castellanos. When Castellanos hit the disabled list in August with a broken hand, McGehee was recalled from Triple-A Toledo for a 30-game stint and slashed .228/.260/.239 with one extra-base hit in 96 PA. His career batting line (.258/.317/.384 over eight seasons) isn’t too shabby, but his age and a long history of knee injuries puts a damper on his potential.
McGehee last appeared in the NPB circuit in 2013, when he signed a one-year, $1.5 million deal with the Tohoku Rakuten Golden Eagles. He spent the bulk of his season at the hot corner, batting an impressive .292/.396/.515 with 28 homers in 590 PA and appearing in the Eagles’ first and only championship run to date.
The deal comes with a club option for 2018, Rosenthal reports, though no figure has been specified.
Free agent left-hander Rich Hill is rumored to be entertaining a three-year, $40+ million offer from the Dodgers, reports Peter Gammons. The Boston Globe’s Nick Cafardo corroborated the report, adding that Hill could receive somewhere between $46 and $48 million from his former team.
Hill, 36, pitched to a 2.12 ERA and 3.91 FIP in back-to-back stints with the Athletics and Dodgers in 2016. While a chronic case of blisters on his pitching hand limited the frequency of his starts, he still figures to be one of the most productive and noteworthy starting pitchers on the market this winter.
The Orioles, Yankees, Red Sox, Rangers and Astros have all been mentioned as potential suitors for the left-hander’s services, though Orioles’ GM Dan Duquette said the club has yet to make a play for Hill and ESPN’s Jim Bowden pointed out that the Red Sox are less involved in trade talks than other interested parties.